Multicenter Clinical Comparison Between Anti‐ NXP2 and Anti‐ TIF1 ‐γ Antibody‐Positive Myositis, and Analysis of the Clinical Significance of Anti‐ NXP2 Antibody Titers in Idiopathic Inflammatory Myopathies
Authors:
- Satoshi KamiyaSKSatoshi Kamiya
- Mariko Ogawa‐MomoharaMOMariko Ogawa‐Momohara
- Yoshinao MuroYMYoshinao Muro
- Satoko YuasaSYSatoko Yuasa
- Masato KakedaMKMasato Kakeda
- Kimiko NakajimaKNKimiko Nakajima
- Mitsuyo KinjoMKMitsuyo Kinjo
- Takako HashimotoTHTakako Hashimoto
- Ken YoshidaKYKen Yoshida
- Takuya TakeichiTTTakuya Takeichi
Open Access
- 16 September 2026
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11) , 1626-1637
Abstract
We aimed to measure anti‐nuclear matrix protein 2 antibody (anti‐NXP2) titers in patients with anti‐NXP2‐positive idiopathic inflammatory myopathies, investigate whether these titers are associated with clinical manifestations, malignancy risk, and treatment response, and compare the clinical and serological features between anti‐NXP2‐positive and anti‐transcriptional intermediary factor 1‐γ antibody (anti‐TIF1‐γ)‐positive dermatomyositis in order to identify practical indicators for differentiating the two subsets. We established a newly optimized in‐house enzyme‐linked immunosorbent assay for the quantitative measurement of anti‐NXP2. After excluding two of the 34 initially identified patients with anti‐NXP2 antibody reactivity, we used the assay to analyse sera from 32 patients with anti‐NXP2‐positive idiopathic inflammatory myopathy. Clinical correlations between anti‐NXP2 titers and inflammatory indices, cardiothoracic ratio, malignancy status, and longitudinal changes after immunosuppressive therapy were examined. We developed a novel clinical scoring system to differentiate between anti‐NXP2‐positive and anti‐TIF1‐γ‐positive myositis. The anti‐TIF1‐γ‐positive patients showed a higher frequency of classic dermatomyositis skin manifestations, whereas the anti‐NXP2‐positive patients had significantly higher creatine kinase, aldolase, and lactate dehydrogenase levels, indicating more prominent muscle involvement. Anti‐NXP2 titers correlated with erythrocyte sedimentation rate and cardiothoracic ratio and were significantly higher in patients with malignancy in the anti‐NXP2‐positive idiopathic inflammatory myopathy patients. Longitudinal analyses demonstrated declines in antibody titers after immunosuppressive treatment. Our scoring system, incorporating age at onset, Gottron's sign, creatine kinase, lactate dehydrogenase, and malignancy status, highly accurately distinguished between anti‐NXP2‐positive and anti‐TIF1‐γ‐positive myositis. Anti‐NXP2 titers reflect systemic inflammation, cardiac involvement, and malignancy risk in anti‐NXP2‐positive idiopathic inflammatory myopathy. The observed decline in anti‐NXP2 titers after therapy suggests the potential utility of these titers as biomarkers for longitudinal disease assessment and stratifying malignancy risk.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP25K11603)
- Japan Science and Technology Agency (JPMJSP2125)
This publication has 22 references indexed in Scilit:
- Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive reviewAutoimmunity Reviews, 2023
- Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohortsClinical Immunology, 2019
- Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis PatientsArthritis Care & Research, 2017
- Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis PatientsArthritis Care & Research, 2017
- Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohortAutoimmunity Reviews, 2014
- Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γArthritis & Rheumatism, 2013
- Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodiesJournal of Autoimmunity, 2005
- Autoantibodies to DFS70/LEDGF are increased in alopecia areata patientsJournal of Autoimmunity, 2004
- Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domainJournal of Autoimmunity, 2004
- Routine vs Extensive Malignancy Search for Adult Dermatomyositis and PolymyositisArchives of Dermatology, 2002